tirzepatide and kidney 🧬 New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve function in patients with obesity, chronic kidney disease (CKD), heart failure with preserved ejection fraction ( Interplay of Chronic Kidney Disease

This makes adequate hydration essential for both safety and effectiveness

ReNew Me Medical Group is Roseville, CA's holistic weight loss and wellness clinic

Learn about how health care professionals diagnose interstitial cystitis with questions about your medical history, a physical exam, and lab and other tests.

Danielle Brightman, clinical director of Numan, argues that a poorly regulated peptide market will set back progress in obesity medication by years and put people in danger.

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

Study of nearly 8,000 patients finds that stopping semaglutide or tirzepatide leads to far less weight regain than clinical trials suggested.